Cervical Cancer Detection Using Optical Spectroscopy
This study is exploring new ways to detect cervical cancer using special light-based devices. Researchers are testing two devices: an Optical Spectroscopy Bench-Top System and a Portable Optical Spectrometer, along with a Transvaginal colposcope (a magnifying device used to examine the cervix). The goal is to find unique "optical signatures" in cervical tissue that could indicate dysplasia (abnormal cell growth that can lead to cancer). You may be able to join if you are a woman aged 18 or older who is having a colposcopy for cervical cancer diagnosis, undergoing LEEP (Loop Electrosurgical Excision Procedure) for early-stage cervical cancer, or having a follow-up Pap smear. The study's current status is unclear.
- Study design
- This interventional study plans to enroll 350 women. It is not specified if it is randomized or blinded.
- What's involved
- The primary measurement, identifying optical signatures, takes less than 10 minutes on the day of the procedure.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Cervical Cancer Detection Using Optical Spectroscopy
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Nimmi Ramanujam, Ph.D. · PRINCIPAL_INVESTIGATOR · Duke University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Identification of optical signatures of cervical tissueDay of procedure (less than 10 minutes)
The primary outcome of this study is the identification of the optical signatures of cervical tissue.